Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study

Ceramides and mitochondrial fatty acid oxidation in obesity

(2017) Raquel Fucho et al.   FASEB JOURNAL

An Analysis of Individual Body Fat Depots and Risk of Developing Cancer

(2017) Arjun Gupta et al.   MAYO CLINIC PROCEEDINGS

Effects of visceral adiposity on glycerol pathways in gluconeogenesis

(2017) Ian J. Neeland et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance

(2017) Max C. Petersen et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans

(2017) Leonore Wigger et al.   Cell Reports

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol

(2016) Reijo Laaksonen et al.   EUROPEAN HEART JOURNAL

Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease

(2016) Panu K. Luukkonen et al.   JOURNAL OF HEPATOLOGY

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

(2016) Walter N. Kernan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Body Fat Distribution and Incident Cardiovascular Disease in Obese Adults

(2015) Ian J. Neeland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose Intolerance

(2014) Sarah M. Turpin et al.   Cell Metabolism

Skeletal muscle ceramide species in men with abdominal obesity

(2014) Maria Pia de la Maza et al.   Journal of Nutrition Health & Aging

The Relationship of Body Mass and Fat Distribution With Incident Hypertension

(2014) Alvin Chandra et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults

(2014) H Hanamatsu et al.   Nutrition & Diabetes

Molecular Lipids Identify Cardiovascular Risk and Are Efficiently Lowered by Simvastatin andPCSK9Deficiency

(2013) Kirill Tarasov et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Role of ceramide in diabetes mellitus: evidence and mechanisms

(2013) Sehamuddin Galadari et al.   Lipids in Health and Disease

Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease

(2013) Marjorie Bastien et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Mechanisms for Insulin Resistance: Common Threads and Missing Links

(2012) Varman T. Samuel et al.   CELL

A Ceramide-Centric View of Insulin Resistance

(2012) Jose A. Chavez et al.   Cell Metabolism

Body Fat Distribution and Risk of Cardiovascular Disease

(2012) Jean-Pierre Després   CIRCULATION

Ceramide and Insulin Resistance: How Should the Issue Be Approached?

(2012) J. Gorski   DIABETES

Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults

(2012) Ian J. Neeland et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Increased Bioactive Lipids Content in Human Subcutaneous and Epicardial Fat Tissue Correlates with Insulin Resistance

(2012) Agnieszka U. Błachnio-Zabielska et al.   LIPIDS

Gluteofemoral body fat as a determinant of metabolic health

(2010) K N Manolopoulos et al.   INTERNATIONAL JOURNAL OF OBESITY

Diagnosis and Classification of Diabetes Mellitus

(2009)   DIABETES CARE

Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance

(2008) J. M. Haus et al.   DIABETES